Clinical Trial Update: Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects [Phase 4]

View source ↗

Summary

Phase 4 study evaluating ease of use and correct use of the placebo Ellipta inhaler in adults with chronic obstructive pulmonary disease; results posted Februar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ELLIPTA Inhaler (placebo)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2017-02-09